Ultragenyx Pharmaceutical

Director, CMC QC Small Molecules

Ultragenyx Pharmaceutical$232K — $287K *
Pharmaceuticals & Biotech
5 - 7 years of experience
Job Overview by Ladders

Qualifications

  • Bachelor's degree with 14+ years, or Master's with 10-12+ years, or PhD with 8-10+ years in GMP-related field.
  • Minimum 5-8+ years of CMC QC experience for small molecule products.
  • Hands-on expertise with analytical techniques like HPLC/UPLC, LC-MS, GC, and compendial testing.
  • Strong knowledge of ICH, FDA, EMA, USP, and Ph. Eur. regulations.
  • Experience managing external QC vendors and laboratories.
  • Experience in global regulatory submissions and inspections.
  • Experience in rare and ultra-rare diseases is a strong asset.

Responsibilities

  • Provide comprehensive QC oversight for outsourced models in drug substance and product.
  • Lead strategic and technical aspects of small molecule QC, ensuring compliance with guidelines.
  • Review and approve outsourced analytical data and method validation.
  • Manage the qualifications and performance of CMOs and contract labs during manufacturing.
  • Collaborate on CMC QC contributions for regulatory submissions and inspections.
  • Provide strategic input for biologics and oligonucleotide programs as needed.
  • Act as a QC representative across cross-functional teams to ensure compliance and quality.

Benefits

  • Generous vacation time and observed public holidays.
  • Volunteer days.
  • Long-term incentive and employee stock purchase plans.
  • Employee wellbeing benefits.
  • Fitness reimbursement.
  • Tuition sponsoring and professional development plans.
Full Job Description
Position Summary:

ultradedicated - Your biggest challenges yield rare possibilities

The Director, CMC Quality Control - Small Molecules is responsible for providing technical and strategic oversight of all outsourced QC activities supporting Ultragenyx small molecule drug substance and drug product programs across development and commercialization. This position reports to the Executive Director, CMC-QC. The role leads QC governance for contract manufacturing organizations (CMOs), contract laboratories (CLs), and other external partners, ensuring compliant, phase-appropriate, and inspection-ready execution. QC testing experience supporting rare and ultra-rare disease development models-characterized by lean organizations, accelerated timelines, and high reliance on outsourced partners-is a strong asset. Experience with biologics QC is considered an additional advantage, particularly for candidates supporting hybrid portfolios in a virtual QC model.
Work Model:

Flex: This role will typically require onsite work 2-3 days each week, or more depending on business needs. In many locations, the business will set certain days each week that Flex employees are required to be onsite.
Responsibilities:
  1. Outsourced QC Oversight
    Provide end-to-end QC oversight for a 100% outsourced operating model, supporting small molecule drug substance and drug product programs across clinical and commercial stages.
  2. CMC QC Leadership - Small Molecules
    Provide technical and strategic leadership for small molecule QC, including solid oral dosage forms and sterile parenterals, with hands-on oversight of analytical testing, method validation, investigations (deviations, OOS), CAPAs, and lifecycle management in compliance with ICH/USP/Ph. Eur./JP requirements.
  3. Analytical & Contract Laboratory Oversight
    Perform technical review and approval of outsourced analytical data, method validation, stability programs, reference standards, specifications, and shelf-life assignments, ensuring phase-appropriate QC strategies and data integrity.
  4. External Partner & CMO/CL Management
    Lead the selection, qualification, and performance management of CMOs and contract laboratories, serving as the QC technical representative during manufacturing campaigns and managing quality agreements, scopes of work, and issue resolution.
  5. Cross-Functional & Regulatory Engagement
    Collaborate cross-functionally and lead CMC QC contributions to regulatory submissions, inspections, and audits, including authoring and defending QC sections and managing responses to health authority observations.
  6. Oligonucleotide Biologics QC (Advantage) - Provide QC oversight or strategic input for biologics and/or oligonucleotide programs, including analytical methods, stability, and regulatory interactions, as needed.
  7. Lead selection, qualification, onboarding, and ongoing performance management of contract laboratories and QC service providers, including governance models, KPIs, and issue escalation.
  8. Act as the QC representative in cross-functional CMC teams, collaborating closely with Technical Operations, Analytical Development, QA, Regulatory Affairs, Supply Chain, and Program Management.
  9. Lead QC support for regulatory inspections and audits involving CMOs and CLs; author and manage responses to QC-related observations and commitments.
Requirements:
  1. Education & Experience
    Bachelor's degree with 14+ years or Master's degree with 10-12+ years, or PhD with 8-10+ years of relevant GMP experience in chemistry, pharmaceutical sciences, biochemistry, or a related discipline.
  2. CMC QC Experience - Small Molecules
    Minimum 5-8+ years of direct CMC QC experience supporting small molecule drug substance and drug product, including commercial assets.
  3. Analytical Technical Expertise
    Demonstrated hands-on expertise with small molecule analytical techniques, including HPLC/UPLC, LC-MS, GC, dissolution, Karl Fischer, particle size, residual solvents, impurity profiling, and compendial safety testing.
  4. Regulatory & Compliance Knowledge
    Strong working knowledge of ICH, FDA, EMA, USP, and Ph. Eur. requirements applicable to small molecule development and commercialization.
  5. Outsourced QC & Vendor Oversight
    Proven experience overseeing external QC laboratories, CMOs, and contract testing organizations, including technical governance and performance management.
  6. Regulatory Submissions & Inspections
    Experience supporting global regulatory submissions and health authority inspections, including defense of outsourced QC data.
  7. Rare & Ultra-Rare Disease Experience (Asset)
    Quality control experience working within rare and/or ultra-rare disease development models, including lean organizations, accelerated timelines, and high reliance on outsourced partners, is a strong asset.
  8. AI & Digital Enablement (Asset)
    Experience applying digital, automation, and/or AI-enabled solutions within QC or CMC environments, such as analytical data review, trend analysis, stability modeling, data integrity monitoring, or outsourced partner performance management, is a strong asset.

#LI-CS1 #LI-Hybrid

The typical annual salary range for this full-time position is listed below. This range reflects the characteristics of the job, such as required skills and qualifications and is based on the office location noted in this job posting. The range may also be adjusted based on applicant's geographic location.

This position is eligible for annual bonus and equity incentives. Actual individual pay is determined by demonstrated experience and internal equity alignment.

Pay Range

$232,600-$287,400 USD

Full Time employees across the globe enjoy a range of benefits, including, but not limited to:

• Generous vacation time and public holidays observed by the company

• Volunteer days

• Long term incentive and Employee stock purchase plans or equivalent offerings

• Employee wellbeing benefits

• Fitness reimbursement

• Tuition sponsoring

• Professional development plans

* Benefits vary by region and country

About Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical is a biopharmaceutical company that develops and markets treatments for rare and ultra-rare genetic diseases. The company's products are designed to address the underlying genetic causes of these diseases. Ultragenyx Pharmaceutical was founded in 2010 and is headquartered in Novato, California. The company has a number of products in development, including treatments for lysosomal storage disorders, metabolic disorders, and skeletal disorders. Ultragenyx Pharmaceutical is committed to improving the lives of patients with rare diseases and has received numerous awards for its work in this area.
Learn more about Ultragenyx Pharmaceutical
Size
1,119 employees
Market Cap
$3 billion
Industry
Net Income
-$186.5 million
Founded
2010
5 Year Trend
+383.5%
Revenue
$271 million
NASDAQ

Similar Jobs

More Jobs at Ultragenyx Pharmaceutical

More Pharmaceuticals & Biotech Jobs

Find similar Director, CMC QC Small Molecules jobs: